Drugs

The Health and Family Welfare Department of Karnataka has urged the Drugs Controller General of India (DCGI) to swiftly investigate and address the issue of substandard Ringer’s lactate IV infusion fluid supplied by Paschim Banga Pharmaceutical, a West Bengal company. […]

Over the past five years, the Pharmaceuticals & Medical Devices Bureau of India (PMBI), overseen by the Department of Pharmaceuticals (DoP), has prohibited six pharmaceutical suppliers from providing medications to Jan Aushadhi Kendras (JAKs) due to their failure to adhere

Supported by Kiran Mazumdar-Shaw, Dr. Ranjan Pai, and various angel investors, UE LifeSciences, a leader in women’s healthcare innovation, is preparing to roll out its RaKSA program aimed at identifying breast, cervical, and oral cancers in primary health centres (PHCs)

HealthCare Global Enterprises (HCG) has teamed up with Accenture to propel advancements in cancer research and treatment by harnessing the power of cutting-edge artificial intelligence (AI), including generative AI and deep learning for multi-dimensional, patient-specific data analysis. This alliance merges

Gland Pharma, specializing in generic injectable pharmaceuticals, has obtained approval from the US Food and Drug Administration (FDA) for their latanoprost ophthalmic solution, 0.005% (2.5 mL Fill). The medication is deemed both bioequivalent and therapeutically comparable to the reference listed

Stallergenes Greer, a firm dedicated to allergen immunotherapy (AIT) solutions, has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given a favorable opinion for broadening Palforzia’s existing use. This development is directed towards

BioNxt Solutions Inc., specializing in cutting-edge drug delivery technologies, has announced its latest project: a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, labeled internally as BNT24005. This groundbreaking product aims to enhance the current administration techniques developed by Novo

AAVantgarde Bio, a clinical-stage biotech firm headquartered in Italy, revealed that the US Food and Drug Administration (FDA) has awarded Orphan Drug Status to its leading initiative, AAVB-081, aimed at treating Usher Syndrome Type 1B (USH1B) retinitis pigmentosa. “Individuals with

Endo, Inc., a versatile company specializing in pharmaceuticals, has unveiled its new Adrenalin premixed bag, marking the first ever epinephrine in 0.9% sodium chloride injection that is FDA-approved and manufacturer-prepared for intravenous (IV) use. “This groundbreaking ready-to-use bag of epinephrine

PTC Therapeutics, Inc., a globally recognized biopharmaceutical firm, has entered into a worldwide license and collaboration agreement with Novartis Pharmaceuticals Corporation, a division of Novartis AG. This partnership centers on PTC518, a program designed to innovate treatment for Huntington’s disease,